Information:
Fel:
ID
13128
Beskrivning
Comparison of Intra-operative Radiotherapy With Post-operative Radiotherapy for Women With Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00983684
Länk
https://clinicaltrials.gov/show/NCT00983684
Nyckelord
Versioner (1)
- 2016-01-18 2016-01-18 -
Uppladdad den
18 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Invasive Breast Cancer NCT00983684
Eligibility Invasive Breast Cancer NCT00983684
- StudyEvent: Eligibility
Similar models
Eligibility Invasive Breast Cancer NCT00983684
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age
Item
age 45 years or older
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
operable invasive breast cancer (t1 and small t2, n0-1, m0) confirmed by cytological or histological examination
boolean
C0010819 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0019638 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0678222 (UMLS CUI [1,2])
C0019638 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
surgery
Item
suitable for breast conserving surgery
boolean
C0038894 (UMLS CUI [1])
contralateral breast cancer
Item
previously diagnosed and treated contralateral breast cancer may be entered but will be randomised to a separate stratum.
boolean
C0678222 (UMLS CUI [1,1])
C0441988 (UMLS CUI [1,2])
C0441988 (UMLS CUI [1,2])
compliance
Item
available for regular follow-up for at least ten years.
boolean
C1321605 (UMLS CUI [1])
ID.6
Item
note: individual centres may wish to restrict entry to a more exactly defined subset of patients, in which case, only patients with these characteristics may be entered by that particular centre. for example, centres may decide at outset to recruit only women over 50 or even over 65 years of age. such policies must be pre-defined in writing and approved by the international steering committee.
text
multifocal carcinoma
Item
more than one obvious cancer in the same breast as diagnosed by clinical examination, mammography or ultrasonography.
boolean
C0678222 (UMLS CUI [1,1])
C0205292 (UMLS CUI [1,2])
C0205292 (UMLS CUI [1,2])
bilateral breast cancer
Item
bilateral breast cancer at the time of diagnosis.
boolean
C0678222 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
C0238767 (UMLS CUI [1,2])
irradiation previous cancer
Item
ipsilateral breast had a previous cancer and/or irradiation.
boolean
C1522449 (UMLS CUI [1])
C0678222 (UMLS CUI [2])
C0678222 (UMLS CUI [2])
brca2
Item
patients known to have brca2 gene mutations, but testing for gene mutations is not required
boolean
C0598034 (UMLS CUI [1])
biopsy, pathology
Item
lobular cancer or extensive intraductal component (eic =>25% of the tumour is intraductal) on core biopsy or initial pathology (if performed)
boolean
C0005558 (UMLS CUI [1])
C0030664 (UMLS CUI [2])
C0030664 (UMLS CUI [2])
neoadjuvant therapy
Item
patients undergoing primary medical treatment (hormones or chemotherapy) as initial treatment with neoadjuvant intent of reducing tumour size should be excluded; those given short duration (up to 4 weeks) systemic therapy can be included.
boolean
C0600558 (UMLS CUI [1])
lymph nodes
Item
patients presenting with gross nodal disease, considered to be clinically malignant or proven cytologically or by scanning. in general, 4 or more positive nodes or extranodal spread are not suitable for targit alone and should receive ebrt as well. however, individual centres may decide that anything more than micrometastasis should receive ebrt.
boolean
C0024204 (UMLS CUI [1])
comorbidity
Item
patients with any severe concomitant disease that may limit their life expectancy.
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
C0392760 (UMLS CUI [1,2])
C0023671 (UMLS CUI [1,3])
cancer
Item
previous history of malignant disease does not preclude entry if the expectation of relapse-free survival at 10 years is 90% or greater.
boolean
C0006826 (UMLS CUI [1])
additional criteria
Item
any factor included as exclusion criterion in the local centre's treatment policy. this is particularly relevant to patients entered into the post pathology stratum.
boolean
C0680251 (UMLS CUI [1])
time
Item
no more than 30 days can have elapsed between last breast cancer surgery (not axillary) and entry into the trial for patients in the post-pathology stratification.
boolean
C0040223 (UMLS CUI [1])